U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C19H27N3O.ClH
Molecular Weight 349.898
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0
Stereo Comments meso

SHOW SMILES / InChI
Structure of RICASETRON HYDROCHLORIDE

SMILES

Cl.CN1[C@H]2CC[C@@H]1C[C@@H](C2)NC(=O)N3CC(C)(C)C4=CC=CC=C34

InChI

InChIKey=KYQBGUPALRZQEE-NFWSUKNGSA-N
InChI=1S/C19H27N3O.ClH/c1-19(2)12-22(17-7-5-4-6-16(17)19)18(23)20-13-10-14-8-9-15(11-13)21(14)3;/h4-7,13-15H,8-12H2,1-3H3,(H,20,23);1H/t13-,14+,15-;

HIDE SMILES / InChI

Molecular Formula C19H27N3O
Molecular Weight 313.4372
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Ricasetron (BRL 46470) is a selective serotonin 5-HT3 receptor antagonist. This compound was found to be a potent anxiolytic agent and have antiemetic (effective against vomiting and nausea) effects when tested in animal models. Moreover, this drug was reported to have less side effects than benzodiazepines (used for anxiety). Ricasetron was not further developed for medical use.

Originator

Approval Year

PubMed

Substance Class Chemical
Record UNII
B8A73VO6UM
Record Status Validated (UNII)
Record Version